Arkolith/Insider Trading/LONA/Form 4

Renninger Robert

CHIEF FINANCIAL OFFICERLeonaBio, Inc. (LONA) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)906$5.37$5K16K
Mar 3, 2026Option exercise(M)4K—$017K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002037968-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML